These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25720849)

  • 1. Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease.
    Galloway PA; El-Damanawi R; Bardsley V; Pritchard NR; Fry AC; Ojha SK; Hiemstra TF
    Nephron; 2015; 129(3):197-201. PubMed ID: 25720849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control study of calciphylaxis in Japanese end-stage renal disease patients.
    Hayashi M; Takamatsu I; Kanno Y; Yoshida T; Abe T; Sato Y;
    Nephrol Dial Transplant; 2012 Apr; 27(4):1580-4. PubMed ID: 22121234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-uremic calciphylaxis due to acenocoumarol].
    Torres-Bondia FI; Parada-Saavedra FJ; Fernández-Armenteros JM; Schoenenberger-Arnaiz JA
    Farm Hosp; 2017 Jul; 41(4):569-570. PubMed ID: 28683713
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.
    Zitt E; König M; Vychytil A; Auinger M; Wallner M; Lingenhel G; Schilcher G; Rudnicki M; Salmhofer H; Lhotta K
    Nephrol Dial Transplant; 2013 May; 28(5):1232-40. PubMed ID: 23291368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenprocoumon based anticoagulation is an underestimated factor in the pathogenesis of calciphylaxis.
    Russ P; Russwurm M; Kortus-Goetze B; Hoyer J; Kamalanabhaiah S
    BMC Nephrol; 2019 Apr; 20(1):114. PubMed ID: 30940121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.
    Brandenburg VM; Kramann R; Rothe H; Kaesler N; Korbiel J; Specht P; Schmitz S; Krüger T; Floege J; Ketteler M
    Nephrol Dial Transplant; 2017 Jan; 32(1):126-132. PubMed ID: 26908770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.
    Gaisne R; Péré M; Menoyo V; Hourmant M; Larmet-Burgeot D
    BMC Nephrol; 2020 Feb; 21(1):63. PubMed ID: 32101140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calciphylaxis: fatal complication of cardiometabolic syndrome in patients with end stage kidney disease].
    Verdalles Guzmán U; de la Cueva P; Verde E; García de Vinuesa S; Goicoechea M; Mosse A; López Gómez JM; Luño J
    Nefrologia; 2008; 28(1):32-6. PubMed ID: 18336128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course].
    Conort O; Siguret V; Bourdon O; Nazaraly S; Brignone M; Pons-Kerjean N; Houze S; Laribe Cage S; Berthet F; Golmard JL; Brion F; Tilleul P
    Ann Pharm Fr; 2014 Jul; 72(4):287-95. PubMed ID: 24997889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased procoagulant phospholipids in patients treated by vitamin K antagonists.
    Rousseau A; Woodhams B; Paunet-Bobo M; Van Dreden P; Bigot D; Leclerc S; Lenormand B; Vasse M
    Thromb Res; 2012 Sep; 130(3):491-4. PubMed ID: 22551976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic nephropathy induced by fluindione must be addressed.
    Cam G; Kwetcheu AT; Vigneau C; Siohan P; Queffeulou G; Gatault P; Laruelle E; Crémault A; Le Cacheux P; Rioux-Leclercq N; Renaudineau E
    Nephrol Dial Transplant; 2012 Apr; 27(4):1554-8. PubMed ID: 21931126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin-induced calciphylaxis successfully treated with sodium thiosulphate.
    Hafiji J; Deegan P; Brais R; Norris P
    Australas J Dermatol; 2013 May; 54(2):133-5. PubMed ID: 23581997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calciphylaxis: an uncertain pathogenesis and controversial treatment].
    Marrón B; Coronel F; López-Bran E; Barrientos A
    Nefrologia; 2001; 21(6):596-600. PubMed ID: 11881431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K.
    Riegert-Johnson DL; Kaur JS; Pfeifer EA
    Mayo Clin Proc; 2001 Jul; 76(7):749-52. PubMed ID: 11444409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis.
    Ruderman I; Toussaint ND; Hawley CM; Krishnasamy R; Pedagogos E; Lioufas N; Elder GJ
    Nephrol Dial Transplant; 2021 Mar; 36(4):649-656. PubMed ID: 31855262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typical features of calciphylaxis in a patient with end-stage renal failure, diabetes mellitus and oral anticoagulation.
    Streit M; Paredes BE; Rüegger S; Brand CU
    Dermatology; 2000; 200(4):356-9. PubMed ID: 10894977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical calciphylaxis in a patient receiving warfarin then resolving with cessation of warfarin and application of hyperbaric oxygen therapy.
    Banerjee C; Woller SC; Holm JR; Stevens SM; Lahey MJ
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):345-50. PubMed ID: 20019019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calciphylaxis in dialysis patients, a severe disease poorly responding to therapies: report of 4 cases.
    Savoia F; Gaddoni G; Patrizi A; Misciali C; Odorici G; Tampieri G; Tampieri E; Cantelli S; Aldi M
    G Ital Dermatol Venereol; 2013 Oct; 148(5):531-6. PubMed ID: 24005147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?
    Meissner M; Gille J; Kaufmann R
    J Dtsch Dermatol Ges; 2006 Dec; 4(12):1037-44. PubMed ID: 17176411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.